Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This study will investigate the efficacy and safety of two doses (high and low) of
empagliflozin in combination with metformin (500 mg and 1000 mg) administered twice daily in
patients with type 2 diabetes mellitus (T2DM). Study will compare four dose combinations of
empagliflozin + metformin versus each individual component after 24 weeks of treatment.